Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Ploeger

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Toxicology and Applied Pharmacology|February 1, 2000
Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cyclingB A Ploeger, J Meulenbelt, J DeJongh
Clinical Pharmacology and Therapeutics|July 9, 2010
Clinical trial simulation: a reviewN Holford, S C Ma, B A Ploeger
Toxicology and Applied Pharmacology|August 10, 1999
Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulationsJ DeJongh, M Nordin-Andersson, B A Ploeger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2017
Population pharmacokinetic characterization of BAY 81-8973, a full-length recombinant factor VIII: lessons learned - importance of including samples with factor VIII levels below the quantitation limitD Garmann, S McLeay, A Shah, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 13, 2011
A hidden Markov model to assess drug-induced sleep fragmentation in the telemetered ratC Diack, O Ackaert, B A Ploeger, et al.
British Journal of Pharmacology|June 26, 2014
Drug effects on the CVS in conscious rats: separating cardiac output into heart rate and stroke volume using PKPD modellingN Snelder, B A Ploeger, O Luttringer, et al.
British Journal of Pharmacology|July 16, 2013
PKPD modelling of the interrelationship between mean arterial BP, cardiac output and total peripheral resistance in conscious ratsN Snelder, B A Ploeger, O Luttringer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Toxicology and Applied Pharmacology|February 1, 2000
Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cyclingB A Ploeger, J Meulenbelt, J DeJongh
Clinical Pharmacology and Therapeutics|July 9, 2010
Clinical trial simulation: a reviewN Holford, S C Ma, B A Ploeger
Toxicology and Applied Pharmacology|August 10, 1999
Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulationsJ DeJongh, M Nordin-Andersson, B A Ploeger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2017
Population pharmacokinetic characterization of BAY 81-8973, a full-length recombinant factor VIII: lessons learned - importance of including samples with factor VIII levels below the quantitation limitD Garmann, S McLeay, A Shah, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 13, 2011
A hidden Markov model to assess drug-induced sleep fragmentation in the telemetered ratC Diack, O Ackaert, B A Ploeger, et al.
British Journal of Pharmacology|June 26, 2014
Drug effects on the CVS in conscious rats: separating cardiac output into heart rate and stroke volume using PKPD modellingN Snelder, B A Ploeger, O Luttringer, et al.
British Journal of Pharmacology|July 16, 2013
PKPD modelling of the interrelationship between mean arterial BP, cardiac output and total peripheral resistance in conscious ratsN Snelder, B A Ploeger, O Luttringer, et al.
Pageof 1